glp-1 china Novo Nordisk's diet drug may land in soon GLP-1RAs for the treatment of
Description
Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...
Health claim ID 3988 pending European approval
Coca-Cola Co
These facts, together with increasing comorbidities in patients with IBD, imply that urgent, more complex, novel therapeutic strategies in the treatment are needed
Learn what results to realistically expect.
Future clinical trials should aim to distinguish the direct analgesic effects of GLP-1RAs from their metabolic benefits and explore their broader applications in pain conditions
